The acquisition boosts BioNTech’s mRNA design and manufacturing capabilities, accelerating development of next-gen cancer ...

The warning letters deal with a range of violations involving items from personal hygienic products to mismarketed analgesics.

Elkedonia will develop first-in-class Elk1 inhibitors for treatment-resistant depression, targeting neuroplasticity without ...

NMPA’s Center for Drug Evaluation accepted Merck KGaA’s application for marketing authorization of pimicotinib as a Class 1 ...

The quickly evolving development of biopharmaceuticals is impacting innovation in the industry overall.

The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry ...

The agreement has been designed to offer a turnkey service to companies seeking faster time to market.

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound ...

Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving ...

Most of the company’s new additions, if not already online, will be scheduled for commissioning, validation, or qualification ...

Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance ...